학술논문
Clinician involvement for ventilator-associated pneumonia surveillance resulted in higher than expected incidence rate reported with implication for attributable mortality.
Document Type
Letter
Author
Source
Subject
*MORTALITY
*RESPIRATORY infections
*
Language
ISSN
2374-4235
Abstract
To the editor, In a study published in this Journal, J. Garnacho-Montero et al. [[1]] reported that quantification of tracheal aspirate samples may not be necessary in ventilated patients clinically suspected of ventilator-associated pneumonia (VAP). Because VAP did not occur at admission but during ICU stay, patients with VAP were included for survival analysis from VAP onset only. Among the 1686 included patients, 129 (7.7%) were diagnosed with VAP: 45 patients (10.3%) had 49 VAP episodes during clinician based surveillance period and 84 patients (6.7%) had 98 VAP episodes during standard surveillance period ( I p i =.019). [Extracted from the article]